Sentences with phrase «by immuno»

Not exact matches

Related Articles: Merck's Keytruda held back by docs who don't want to wait for diagnostics Bristol's Opdivo - Yervoy combo ups response rates in first - line lung cancer patients Roche's Tecentriq bursts onto immuno - oncology scene, with Merck and BMS in its sights Bristol - Myers» new Opdivo ad touts biomarker advantage over Merck's Keytruda Merck's Keytruda lines up its survival data for stepped - up battle with BMS» Opdivo

The adjusted tally beat consensus expectations of $ 1.00, thanks in part to stronger demand for its standout immuno - oncology drug KEYTRUDA, and management responded by raising its full - year guidance.

Much current research in immuno - oncology focuses on improving these treatments, for example, by finding new immunotherapy targets and identifying biomarkers that predict a patient's response.

They did it by delivering immuno - modulatory compounds — specifically, the bioactive protein interleukin - 10 — into the inflamed intestine, which reduced both the speed and severity of polyp formation.

By June 2015, the transformation was largely complete, with BMS renewing its focus on the abovementioned areas and also on immuno - oncology, where it held a huge lead over the competition.

The researchers suggest that their blood test serves as a cheap and simple option to pre-select individuals from the general population for further testing by these more invasive and costly methods to exclude the falsely positive subjects.The blood test developed by Gerwert and colleagues uses a technology called immuno - infrared sensor to measure distribution of pathological and healthy structures of amyloid - beta.

According to a report by the industry group PhRMA, almost 250 immuno - oncology medicines and vaccines were in development in 2017.

Grape - like structures of viral replication territories in the nucleus of a human cell visualized by click - chemistry and immuno - fluorescence confocal microscopy.

Seres Therapeutics, Inc. (NASDAQ: MCRB) today announced that new preclinical data supporting the development of microbiome therapeutics for immuno - oncology (leveraging gut microbiota to impact tumor immunotherapy) 1 will be presented today by Sceneay et al in the late breaking poster session at the 2018 American Association for Cancer Research Annual Meeting (AACR) in Chicago.

VentiRx will provide motolimod, the company's lead immuno - oncology agent, for the study, which will be conducted by Ludwig and CRI through their jointly coordinated CVC Trials Network.

The project associates the expertise of IRIBHM in GPCR discovery and validation, the unique technology on sensory GPCRs developed by ChemCom, the in - depth tumor immunology expertise of de Duve with the drug discovery capabilities of iTeos and the expertise of ImmunXperts with human primary cells in immuno - oncology.

This will fast - track new immune - modulating therapies for cancer patients by discovering and developing small molecule product candidates against immuno - oncology targets.

Previous studies of neuron survival by the Priestley lab have confirmed with toluidine blue histochemistry that NeuN immuno - reactivity is a reliable marker of neuron survival after spinal cord injury [34].

SAN DIEGO, March 28, 2017 (GLOBE NEWSWIRE)-- Invivoscribe ® Technologies Inc., a global company with decades of experience providing internationally standardized clonality and biomarker testing solutions for the fields of oncology, personalized molecular diagnostics ®, and personalized molecular medicine ®, reports that its next - generation sequencing (NGS) LymphoTrack ® Assay kits are being used by its LabPMM ® clinical laboratories, pharmaceutical partners, and cancer centers to identify and monitor chimeric antigen receptor T - cells (CAR - T) and engineered T - cell receptors in peripheral blood of subjects in support of immuno - therapeutic drug development and treatment regimen development for both hematologic and solid tumors.

One way that they do this is by targeting young, sick, weak or immuno - compromised animals first.

Andrew Burbidge: We have looked in Australia at biological control of foxes and rabbits and house mice at various times, particularly in the late»80s and»90s, there was work done within CSIRO, funded by the federal government, to see whether you could develop the idea of immuno - contraception.

Andrew Burbidge: Yes, I think that having a transmissible virus as the vector for immuno - contraception or whatever other technique's available is not really a viable option because the feral cat has been bred from the wild cat of Africa, Europe and Asia, and if that transmissible disease, that virus escaped Australia or was taken out purposely by someone who, you know, wanted to cause problems in another country, then we would have actually have developed a technique for eradicating native animals in other people's countries, and I just think that's not on.